Venous Thromboembolism Following Acute Ischemic Stroke: A Prospective Incidence Study
Journal of Neurocritical Care. 2018;11(2):102-109 
Prevention of venous thromboembolism after acute ischemic stroke
Journal of Thrombosis and Haemostasis. 2005;3(6):1187-1194
Venous Thromboembolism Prophylaxis following Acute Ischemic Stroke: A Retrospective Comparison of Unfractionated Heparin, Enoxaparin, and Fondaparinux
Hospital Pharmacy. 2011;46(2):110-116
Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study
Journal of Thrombosis and Haemostasis. 2003;1(1):88-94
Venous Thromboembolism in the Get With The Guidelines-Stroke Acute Ischemic Stroke Population: Incidence and Patterns of Prophylaxis
Journal of Stroke and Cerebrovascular Diseases. 2014;23(1):123-129
Differences Between Low-Molecular-Weight and Unfractionated Heparin for Venous Thromboembolism Prevention Following Ischemic Stroke
Chest. 2008;133(1):149-155
PM317 Incidence of Deep Venous Thrombosis Among Admitted Patients at High Risk for Venous Thromboembolism: A Prospective Study
Global Heart. 2016;11(2):e125
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
ClinicoEconomics and Outcomes Research. 2012;99
Revisiting ‘progressive stroke’: incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke
Journal of Neurology. 2017;265(1):216-225
Prevention of Venous Thromboembolism, Recurrent Stroke, and Other Vascular Events After Acute Ischemic Stroke: The Role of Low-Molecular-Weight Heparin and Antiplatelet Therapy
Journal of Stroke and Cerebrovascular Diseases. 2006;15(6):250-259